03.02.2011 • NewsCFODr. Bernhard DüttmannLanxess

Dr. Bernhard Düttmann to Become Chief Financial Officer (CFO) of Lanxess

Dr. Bernhard Duettmann, next Lanxess CFO
Dr. Bernhard Duettmann, next Lanxess CFO

The Supervisory Board of Lanxess agreed today to revoke the contract of Matthias Zachert (43), Member of the Board of Management and Chief Financial Officer, as of March 31, 2011. Zachert had requested the Board to do so accordingly. In his current function, he has been a Member of the Board of Management since 2004.

Dr. Bernhard Düttmann (51), previously Member of the Board of Management and Chief Financial Officer of Beiersdorf, Hamburg, has been appointed Member of the Board of Management and Chief Financial Officer of Lanxess as of April 1, 2011.

"The Supervisory Board is pleased to have gained an experienced Chief Financial Officer of a recognized company for the CFO role at Lanxess and would like to wish him success in his new position."

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.